RxSight Inc. conducted its Annual Meeting of Stockholders on June 3, 2025. During the meeting, stockholders re-elected Ron Kurtz, M.D., J. Andy Corley, and Juliet Tammenoms Bakker as Class I directors. Additionally, the stockholders approved the compensation of named executive officers. The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was also ratified.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RxSight Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-081636), on June 04, 2025, and is solely responsible for the information contained therein.